rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2003-7-28
|
pubmed:abstractText |
We evaluated the renoprotective effects as reflected by short-term changes in albuminuria of dual blockade of the renin-angiotensin system (RAS) by adding an angiotensin II receptor blocker (ARB) to treatment with maximal recommended doses of an ACE inhibitor (ACEI) in patients with type 2 diabetes and nephropathy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0149-5992
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2268-74
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:12882847-Aged,
pubmed-meshheading:12882847-Angiotensin Receptor Antagonists,
pubmed-meshheading:12882847-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:12882847-Antihypertensive Agents,
pubmed-meshheading:12882847-Benzimidazoles,
pubmed-meshheading:12882847-Captopril,
pubmed-meshheading:12882847-Cross-Over Studies,
pubmed-meshheading:12882847-Diabetes Mellitus, Type 2,
pubmed-meshheading:12882847-Diabetic Nephropathies,
pubmed-meshheading:12882847-Double-Blind Method,
pubmed-meshheading:12882847-Drug Therapy, Combination,
pubmed-meshheading:12882847-Enalapril,
pubmed-meshheading:12882847-Female,
pubmed-meshheading:12882847-Humans,
pubmed-meshheading:12882847-Kidney,
pubmed-meshheading:12882847-Lisinopril,
pubmed-meshheading:12882847-Male,
pubmed-meshheading:12882847-Middle Aged,
pubmed-meshheading:12882847-Tetrazoles,
pubmed-meshheading:12882847-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.
|
pubmed:affiliation |
Steno Diabetes Center, Gentofte, Denmark. krossing@dadlnet.dk
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|